Role of inflammation in the process of clinical Kashin-Beck disease: latest findings and interpretations

Inflamm Res. 2015 Nov;64(11):853-60. doi: 10.1007/s00011-015-0861-6. Epub 2015 Aug 11.

Abstract

Kashin-Beck disease (KBD), a particular type of osteoarthritis (OA), and an endemic disease with articular cartilage damage and chondrocytes apoptosis, can affect many joints, and the most commonly affected joints are the knee, ankle, and hand. KBD has traditionally been classified as a non-inflammatory OA. However, recent studies have shown that inflammation has played an important role in the development of KBD. Nowadays, clinical KBD is not only an endemic disease, but also a combined result of many other non-endemic factors, which contains age, altered biomechanics, joint trauma and secondary OA. The characteristics of the developmental joint failure of advanced KBD, because of the biochemical and mechanical processes, are tightly linked with the interaction of joint damage and its immune response, as well as the subsequent state of chronic inflammation leading to KBD progression. In this review, we focus on the epidemiology, pathology, imaging, cytokines and transduction pathways investigating the association of inflammation with KBD; meanwhile, a wide range of data will be discussed to elicit our current hypotheses considering the role of inflammation and immune activation in KBD development.

Keywords: Immune response; Inflammation; Kashin-Beck disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cartilage, Articular / pathology
  • Humans
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / pathology
  • Kashin-Beck Disease* / drug therapy
  • Kashin-Beck Disease* / immunology
  • Kashin-Beck Disease* / pathology